PROKPROKIDNEY CORP.

Nasdaq prokidney.com


$ 2.65 $ 0.19 (7.85 %)    

Thursday, 09-May-2024 15:54:52 EDT
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 2.61
$ 2.49
$ 0.00 x 0
$ 0.00 x 0
$ 2.49 - $ 2.65
$ 1.12 - $ 13.51
504,837
na
161.07M
$ 0.95
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-28-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-11-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 03-23-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-ultragenyx-pharmaceutical-shares-are-trading-lower-by-around-9-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new d...

 morgan-stanley-assumes-prokidney-at-equal-weight-announces-price-target-of-3

Morgan Stanley analyst Judah Frommer assumes ProKidney (NASDAQ:PROK) with a Equal-Weight rating and announces Price Target o...

 b-of-a-securities-downgrades-prokidney-to-neutral-lowers-price-target-to-2

B of A Securities analyst Jason Gerberry downgrades ProKidney (NASDAQ:PROK) from Buy to Neutral and lowers the price target ...

 prokidney-corp-files-for-mixed-shelf-offering-of-500m

-SEC Filing

 why-childrens-place-shares-are-trading-lower-by-around-25-here-are-other-stocks-moving-in-thursdays-mid-day-session

Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.

 prokidney-announces-updated-positive-interim-diabetic-ckd-data-from-its-rmcl-002-phase-2-study

Updated positive interim Phase 2 data demonstrate potential efficacy of REACT to preserve kidney function in moderate and high-...

 stocks-that-hit-52-week-lows-on-thursday

  During the session on Thursday, 461 stocks hit new 52-week lows.

 why-terran-orbital-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Gainers Connexa Sports Technologies Inc. (NASDAQ: CNXA) shares jumped 124.2% to $0.1697 after falling 15% on Monday.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION